Gossamer Bio Announces First Quarter 2019 Financial Results
– Multiple trial initiations and data readouts expected in the next 12 months – – Company to host conference call…
Pharmaceuticals, Biotechnology and Life Sciences
– Multiple trial initiations and data readouts expected in the next 12 months – – Company to host conference call…
Abstract will be presented at the 2019 American Thoracic Society (ATS) International Conference in Dallas FT. WORTH, Texas–(BUSINESS WIRE)–NanOlogy LLC,…
— Dr. C.A. (Oscar) Izeboud, Managing Director at NIBC Bank N.V., strengthens Board with first-hand experience in medtech and financial…
Excellent FY2018 results driven by key growth products and strict Opex discipline, with Legacy Takeda1 greatly exceeding original guidance and…
Immediate access to German medical cannabis market LONDON–(BUSINESS WIRE)–EMMAC Life Sciences Ltd (“EMMAC” or the “Company”), the European independent medical…
5 new chemical entities advancing in pipeline 9 significant regulatory submissions planned from 2019 to 2022 2022 financial outlook of…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to…
IQVIA MedTech provides innovative technology, focused solutions and consulting services to meet the industry-specific needs of this life sciences segment…
PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (NASDAQ:ADXS) (the “Company”), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products,…
This partnership will also include sister platform The American Journal of Managed Care® CRANBURY, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AJMC?src=hash" target="_blank"gt;#AJMClt;/agt;–Targeted Oncology™, a…